, Development and
Evaluation) system. There are limited Level I data available for many of the critical questions in the ﬁeld, demonstrating the
urgent need for comparative effectiveness research in PAD. Emphasis is placed on risk factor modiﬁcation, medical therapies, and
broader use of exercise programs to improve cardiovascular health and functional performance. Screening for PAD appears of
unproven beneﬁt at present. Revascularization for IC is an appropriate therapy for selected patients with disabling symptoms